| |
Biotechnology Stock Reports Bundle
Number of Reports: 25
Format: PDF
Price: 250.00
|
|
|
Stocks Profiled: Affymetrix Inc, Amgen Inc, Amylin Pharmaceuticals, Celgene Corp, Cephalon Inc, Genzyme Corp, Gilead Sciences, Human Genome Sciences, Biogen Idec, NPS Pharmaceuticals, Neurocrine Biosciences, OSI Pharmaceuticals, PDL BioPharma, Regeneron Pharmaceuticals, Vertex Pharmaceuticals, Vical Inc, QIAGEN N V, Trimeris Inc, Maxygen Inc, Exelixis Inc, Charles River Labs Intl, Illumina Inc, GTx Inc, Cytokinetics Inc, Idenix Pharmaceuticals
|
|
Product Description
|
Standard & Poor's Stock Reports offer up-to-date, reliable data and objective analysis on approximately 5,000 publicly held U.S. corporations, prepared by our team of highly regarded Equity Research analysts. With their broad array of fundamental, quantitative, and technical data, and in-depth synopsis of each company's business, developments, performance and outlook, S&P Stock Reports are an essential resource for identifying investment opportunities and evaluating portfolio performance and strategies. Now redesigned with added features, S&P Stock Reports are easier than ever to use but still packed with the reliable information and analysis you've come to expect from Standard & Poor's. Added features include Standard & Poor's Target Prices, Standard & Poor's Core Earnings, Industry Classifications (GICS), a STARS* Performance Chart, Earnings Analysis, and a new Glossary, among other items.
*Stock Appreciation Ranking System
|
| Biotechnology Industry Survey and Stock Reports Bundle | | Purchase both the Biotechnology Industry Survey and the Biotechnology Stock Reports Bundle and receive a discount! |
|
|
|
|
